APA (7th ed.) Citation

Chiba, S., Kiso, M., Nakajima, N., Iida, S., Maemura, T., Kuroda, M., . . . Kawaoka, Y. (2022). Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model. mBio, 13(1), e0304421. https://doi.org/10.1128/mbio.03044-21

Chicago Style (17th ed.) Citation

Chiba, Shiho, et al. "Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model." MBio 13, no. 1 (2022): e0304421. https://doi.org/10.1128/mbio.03044-21.

MLA (9th ed.) Citation

Chiba, Shiho, et al. "Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model." MBio, vol. 13, no. 1, 2022, p. e0304421, https://doi.org/10.1128/mbio.03044-21.